Elanco Animal Health Inc (ELAN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ELAN currently has 498M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.77% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 497.7M shares outstanding |
500M | 0 |
| Nov 05, 2025 |
10-Q filing | 496.8M shares outstanding |
500M | 0 |
| Aug 07, 2025 |
10-Q filing | 496.6M shares outstanding |
500M | 0 |
| May 07, 2025 |
10-Q filing | 495.1M shares outstanding |
500M | 0 |
| Feb 25, 2025 |
10-K filing | 494.0M shares outstanding |
490M | 0 |
| Nov 07, 2024 |
10-Q filing | 494.3M shares outstanding |
490M | 0 |
| Aug 08, 2024 |
10-Q filing | 494.2M shares outstanding |
490M | 0 |
| May 08, 2024 |
10-Q filing | 493.2M shares outstanding |
490M | 0 |
| Feb 26, 2024 |
10-K filing | 492.3M shares outstanding |
490M | 0 |
| Nov 07, 2023 |
10-Q filing | 492.7M shares outstanding |
490M | 0 |
| Aug 07, 2023 |
10-Q filing | 492.6M shares outstanding |
490M | 0 |
| May 09, 2023 |
10-Q filing | 492.8M shares outstanding |
490M | 0 |
| Mar 01, 2023 |
10-K filing | 488.3M shares outstanding |
490M | 0 |
| Jan 31, 2023 |
8-K filing: Elanco Animal Health Incorporated announced the settlement rate for its outstanding 5.00% Tangible Equity Units, with holders receiving 1.5625 shares of Elanco's common stock for each prepaid stock purchase contract, resulting in the issuance of approximately 17.2 million shares of Common Stock on February 1, 2023. |
490M | 0 |
| Nov 08, 2022 |
10-Q filing | 488.4M shares outstanding |
490M | 0 |
| Aug 08, 2022 |
10-Q filing | 488.4M shares outstanding |
490M | 0 |
| May 09, 2022 |
10-Q filing | 488.0M shares outstanding |
490M | 0 |
| Feb 28, 2022 |
10-K filing | 487.2M shares outstanding |
490M | 0 |
| Nov 05, 2021 |
10-Q filing | 487.3M shares outstanding |
490M | 0 |
| Aug 09, 2021 |
10-Q filing | 487.3M shares outstanding |
490M | 0 |
| May 07, 2021 |
10-Q filing | 486.7M shares outstanding |
490M | 0 |
| Mar 01, 2021 |
10-K filing | 441.4M shares outstanding |
440M | 0 |
| Dec 17, 2020 |
8-K filing: Elanco Animal Health Incorporated announced the exercise in full of the underwriters' option to purchase an additional 8,175,000 shares of Elanco's common stock from Bayer World Investments B.V. at a price of $30.25 per share, less underwriting discounts, in connection with the previously announced underwritten public offering of 54,500,000 shares, which closed on December 3, 2020. |
460M | 0 |
| Dec 03, 2020 |
8-K filing: Bayer sold 54,500,000 shares of Elanco's common stock at a price of $30.25 per share in a public offering that closed on December 3, 2020, with an option for underwriters to purchase an additional 8,175,000 shares. |
460M | 0 |
| Nov 06, 2020 |
10-Q filing | 462.4M shares outstanding |
460M | 0 |
| Jul 30, 2020 |
10-Q filing | 413.2M shares outstanding |
410M | 0 |
| May 07, 2020 |
10-Q filing | 403.9M shares outstanding |
400M | 0 |
| Feb 28, 2020 |
10-K filing | 370.3M shares outstanding |
370M | 0 |
| Jan 27, 2020 |
8-K filing: Elanco Animal Health Incorporated sold 24,964,205 shares of its common stock at a public offering price of $32.00 per share and 11,000,000 of its 5.00% tangible equity units at a public offering price of $50.00 per Unit. ($550.0M proceeds) |
N/A | 0 |